期刊文献+

支气管肺泡灌洗液中CYFRA21-1、NSE和CEA联合检测对肺癌的诊断价值 被引量:5

Diagnostic value of combined detecting of CYFRA21-1,NSE and CEA in BALF of lung carcinoma patients
下载PDF
导出
摘要 目的:探讨支气管肺泡灌洗液(BALF)中可溶性细胞角蛋白19片段(CYFRA21-1)、神经元特异性烯醇化酶(NSE)和癌胚抗原(CEA)联合检测对肺癌的诊断价值。方法:肺癌患者45例和肺良性病变患者20例(对照组),按照纤维支气管镜操作技术常规取2组对象的BALF,采用免疫放射法检测CYFRA21-1、NSE的水平,采用放射免疫法检测CEA的水平。绘制BALF中CYFRA21-1、NSE和CEA3种标志物的受试者工作特征曲线(ROC),确定临界值,以≥临界值为阳性,计算敏感度、特异度及约登指数。结果:肺癌组BALF中CYFRA21-1、NSE和CEA的最佳临界点值分别为为36.25、7.87和25.91μg/L。3者联合检测串联试验的约登指数为51.7%,高于非联合检测时各单项指标的约登指数(CYFRA21-1为32.1%,NSE为30.0%,CEA为25.6%)。联合检测并联试验的约登指数为40%,但特异度可达100%。结论:BALF中CYFRA21-1、NSE及CEA联合检测可提高肺癌诊断率,降低漏诊率。 Aim:To evaluate the diagnostic value of combined detecting cytokeratin 19 fragment(CYFRA21-1),neuron specific enolase(NSE) and carcinoembryonic antigen(CEA) in bronchoalveolar lavage fluid(BALF) of patients with lung cancer.Methods:The expressions of CYFRA21-1 and NSE in BAIF of 45 cases of lung cancer and 20 cases of benign lesion were detected by immunoradiometric assay(IRMA),and CEA was detected by radioimmunoassay(RIA).Drawing the receive operator characteristic(ROC) curve of CYFRA21-1,NSE and CEA in BALF by the SPSS 10.0 software.Determining the critical point by ROC curve,calculated the sensitivity and specificity and Youden's index.Results:The best critical point of CYFRA21-1,NSE and CEA in BALF in lung cancer group was 36.25,7.87,and 25.91 μg/L.The Youden' s index of the combined parallel trial in lung cancer grops was higher than that in single marker(51.7% vs 32.2%,30.0%,and 25.6%),although the specificity decreased to 65.0%.In series trial,the Youden's index is 40.0%,but the specificity was up to 100.0%.Conclusion:The combination of three tumor markers in BALF could increase the diagnostic value of lung cancer.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第4期618-621,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 肺癌 支气管肺泡灌洗液 可溶性细胞角蛋白19片段 神经元特异性烯醇化酶 癌胚抗原 lung cancer bronchoalveolar lavage fluid cytokeratin 19 fragment neuron specific enolase carcinoembryonic antigen
  • 相关文献

参考文献9

  • 1陈灏珠.实用内科学[M].北京:人民卫生出版社,2009. 被引量:613
  • 2Barlesi F, Gimenez C, Torre JP, et al. Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer [ J ]. Respir Med, 2004,98 (4) : 357. 被引量:1
  • 3Buccheri G, Ferrigno D. Cytokeratin-derived markers of lung cancer [ J ]. Expert Rev Mol Diagn, 2001,1 ( 3 ) :315. 被引量:1
  • 4Stieber P, Hasholzner U, Bodenmuller H, et al. CYFRA 21 - 1 : a new marker in lung cancer [ J ] . Cancer, 1993 , 72(3) :707. 被引量:1
  • 5Ychou M, Khemissa-Akouz F, Kramar A,et al. A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma [ J]. Bull Cancer, 2001,88(10) :1 023. 被引量:1
  • 6Muraki M, Tohda Y, Iwanaga T,et al. Assessment of serum CYFRA 21-1 in lung cancer[J]. Cancer,1996,77(7) : 1 274. 被引量:1
  • 7Karnak D, Ulubay G, Kayacan O, et al. Evaluation of Cyfra 21-1 : a potential tumor marker for non-small cell lung carcinomas[J]. Lung,2001,179(1):57. 被引量:1
  • 8Mroczko B, Szmitkowski M, Niklinski J. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer[ J ]. Clin Chem Lab Med,2001,39(5) :374. 被引量:1
  • 9de Diego A, Compte L, Sanchis J,et al. Usefulness of carcinoembryonic antigen determination in bronchoalveolar lavage fluid: a comparative study among patients with peripheral lung cancer, pneumonia, and healthy individuals [J]. Chest,1991,100(4) :1 060. 被引量:1

共引文献612

同被引文献37

  • 1李白云,李继昌,陈健,司莲芝,周冬菊,张瑜卿,林晓银,邢陆伟,郭新珍,阎增亮,油书恒.胃癌、食管癌患者血清和组织中低密度脂蛋白及胆固醇含量的测定[J].河南医科大学学报,1993,28(2):137-139. 被引量:12
  • 2王春祥,王培林,智绪亭.胃癌患者手术前后血浆胆固醇水平研究[J].中国现代普通外科进展,2005,8(4):240-242. 被引量:11
  • 3陈文彬.诊断学[M].7版.北京:人民卫生出版社,2008:35-37. 被引量:169
  • 4孙燕.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2008:597. 被引量:57
  • 5Dessi S, Batetta B, Anchisi C, et al. Cholesterol metabolism during the grouth of rat ascites nepatoma (YoshidaAH130) [J]. BrJCancer,1992,66(5):787. 被引量:1
  • 6Dessi S, Batetta B, Pulisci D, et al. Cholesterol content in tumor tissues is inversely associated with high-density lipo- protein cholesterol in serumin patients with gastrointestinal cancer [ J ]. Cancer, 1994,73 ( 2 ) : 253. 被引量:1
  • 7Tomiki Y, Suda S, Tanaka M, et al. Reduced low-density lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study [J]. J Exp Clin Cancer Res, 2004,23 (2) :233. 被引量:1
  • 8陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775. 被引量:2785
  • 9ROTH K, HARDIE JA, ANDREASSEN AH, et al. Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study com- paring different combinations of sampling techniques [ J ]. BMC Pulm Med,2008,8( 1 ) :2 -8. 被引量:1
  • 10SHAHID M, MALIK A, BHARGAVA R. Bronehogenic carcino- ma and secondary aspergillosis-commonyet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis [ J ]. Cancer,2008,113 (3) :547 - 558. 被引量:1

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部